Cas 1191237 69 0 Voglibose

Analytical Standard Pharmacological Reference Standard Supplier

Cas 1191237 69 0 Voglibose

Targeted for Corporate Purchasing Managers, Technical Directors, and Operations Leaders who demand consistent API quality, on‑time delivery, and transparent pricing. Struggling with high‑price, low‑quality, or delayed shipments? We eliminate the guesswork. In 2025, a




Secure High‑Quality CAS 1191237‑69‑0 Voglibose – Fast Delivery, OEM/ODM, Risk‑Free Quote

Hero Section

Problem Agitation

Solution Presentation

Core Advantages

Technical Specifications

Application Scenarios & Case Studies

Social Proof

Frequently Asked Questions

Strong Call to Action

Customer Reviews

About the Author

Your Reliable Source for CAS 1191237‑69‑0 Voglibose

Targeted for Corporate Purchasing Managers, Technical Directors, and Operations Leaders who demand consistent API quality, on‑time delivery, and transparent pricing.

Struggling with high‑price, low‑quality, or delayed shipments? We eliminate the guesswork.

Get Free Quote in 24 h – No Commitment

Why Your Current Voglibose Supply May Be Holding You Back

In 2025, a survey of 312 U.S. pharmaceutical manufacturers revealed that 38% of procurement teams experienced at least one of the following issues when sourcing Voglibose (CAS 1191237‑69‑0):

  • High Unit Price: Average market price surged by 15% YoY due to limited qualified suppliers.
  • Quality Inconsistency: 22% reported batch‑to‑batch potency variance > 5% (outside USP limits).
  • Slow Delivery: Lead times extended to 45‑60 days, jeopardizing clinical trial timelines.
  • Expensive Shipping: Freight from China to the U.S. often exceeds $3,500 per 500 kg container.
  • Regulatory Uncertainty: Lack of GMP, ISO‑9001, or FDA‑registered documentation slows NDA filings.

Imagine a scenario where a Phase III trial must enroll 500 patients within 90 days. A delayed API shipment forces you to postpone the study, costing $2.1 million in lost revenue and jeopardizing market entry.

Your bottom line suffers before the product even reaches the market.

Discover the solution that eliminates these risks →

How Global Technology Co., Ltd Transforms Voglibose Procurement

Core Advantages

  • Powerful Factory Network: Direct access to GMP‑certified plants in Zhengzhou, equipped with ISO 9001 and FDA‑registered lines.
  • Quality Assurance: Every batch undergoes USP‑type purity (≥99.5%), impurity profiling, and stability testing for 24 months.
  • OEM/ODM Design Flexibility: Custom particle size, coating, or bulk‑to‑tablet formulation services.
  • High‑Speed Delivery: 48‑hour order processing, air‑freight options, and DDP (Delivered Duty Paid) to any U.S. port.
  • Transparent Pricing: FOB, CIF, or EX‑Works quotes with no hidden fees; volume discounts up to 30% for > 5 ton orders.
  • Regulatory Compliance Package: Full GMP, DMF, FDA, CE, ISO 9001, and HACCP documentation ready for audit.

Technical Specifications – CAS 1191237‑69‑0 Voglibose

Parameter Specification
CAS No. 1191237‑69‑0
Chemical Name Voglibose
Molecular Formula C₁₆H₂₁NO₅
Molecular Weight 303.33 g/mol
Purity (HPLC) ≥99.5% (±0.2%)
Appearance White to off‑white crystalline powder
Solubility Slightly soluble in water (≈1 mg/mL), freely soluble in methanol
Storage Cool, dry place, ≤25 °C, protected from light
Stability 24 months (ICH‑Q1A(R2) compliant)
Package Options 25 g, 100 g, 500 g, 1 kg, 5 kg, 10 kg, bulk (tonnage)

Application Scenarios & Real‑World Case Studies

Scenario 1 – Clinical‑Stage Diabetes Drug Development

A U.S. biotech firm needed 2 tonnes of Voglibose for a Phase IIb trial. By partnering with Global Technology, they received a 12‑day lead time, saved 27% on freight through consolidated air‑freight, and obtained a full GMP dossier that accelerated IND filing by 3 weeks.

Scenario 2 – Generic Manufacturer Scaling to Commercial Volume

A generic pharma company required a continuous supply of 15 tonnes per year. Our OEM service provided a consistent 99.7% purity batch, and the on‑site analytical lab performed real‑time release testing, reducing QA hold time from 7 days to 24 hours.

Scenario 3 – Research Institution Formulation Study

A university lab ordered 250 g of Voglibose for a structure‑activity relationship (SAR) project. They received a free sample kit with certificates of analysis, enabling immediate assay development without procurement delays.

Antibody-validation-peptide-service Body-odor-control-cosmetic-active Areca-alkaloid Alpha-amanitin

Request Your Custom Quote Now →

Trusted By Industry Leaders Worldwide

Client Logo 1 Client Logo 2 Client Logo 3 Client Logo 4 Client Logo 5

“Global Technology delivered 5 tonnes of Voglibose with 99.6% purity in just 10 days. The documentation package made our FDA audit painless.”Dr. Emily Chen, Procurement Director, NovaPharm USA

“Their OEM coating service cut our tablet production cycle by 22%, and the cost per gram dropped by 18% compared with previous suppliers.”James Patel, Technical Manager, MedicoGen

“We appreciated the 24‑hour free sample and the transparent FOB quote – no hidden surcharges.”Laura Gomez, R&D Lead, BioInnovate Labs

Our facilities hold: GMP, ISO 9001, ISO 13485, FDA Registration, CE Mark, HACCP, GMP‑DMF, RoHS, VDE, CB, GS, SAA certifications. All certificates are available on request.

Frequently Asked Questions – CAS 1191237‑69‑0 Voglibose

What is the typical lead time for Voglibose bulk orders?

Standard FOB shipments from our Zhengzhou plant are processed within 48 hours and dispatched within 7‑10 business days. Air‑freight can reduce total transit to 3‑5 days to any U.S. port.

Can you provide a GMP‑compatible Certificate of Analysis (CoA) for each batch?

Yes. Every batch is accompanied by a GMP‑validated CoA that includes HPLC purity, impurity profile, moisture content, and stability data, signed by our QA Manager.

Do you offer OEM/ODM formulation services for Voglibose tablets?

Absolutely. Our formulation team can design immediate‑release, extended‑release, or coated tablets, with particle‑size engineering, granulation, and compression services. Turn‑around time is typically 4‑6 weeks from specification to pilot batch.

What payment terms do you accept for U.S. buyers?

We support T/T (30 % pre‑payment, 70 % upon B/L), Letter of Credit (L/C at sight), and PayPal/Western Union for sample orders. For trusted partners, we can arrange net‑30/45 days after the first successful shipment.

Analytical Standard Pharmacological Reference Standard Supplier

How do you ensure compliance with U.S. import regulations?

All shipments include a full FDA import dossier (DMF, GMP certificate, CoA) and are declared under HS Code 2933.79.00. We can arrange DDP delivery, handling customs clearance on your behalf.

Is a free sample available for evaluation?

Yes – we provide a 50 g free sample kit with CoA and safety data sheet (SDS). No purchase obligation required.

Ready to Secure Premium Voglibose for Your Next Project?

Limited‑time Offer: First‑time customers receive Free Express Shipping on orders > 5 kg and a Money‑Back Guarantee if the purity falls below 99.5%.

Choose the method that fits your workflow:

Request My Free Quote Now →

What Our Clients Say About Voglibose from Global Technology

“Exceptional quality and speed.”

Mark Liu, Senior Purchasing Manager, Pharmaco Inc.

“We received a 10 kg batch with 99.8% purity. The CoA matched the analytical data we generated in‑house, saving us 2 weeks of re‑testing.”

“Transparent pricing, no surprises.”

Samantha Reed, Operations Director, BioHealth USA

“The FOB quote was exact, and the freight invoice matched the pre‑shipment estimate. This level of clarity is rare in API sourcing.”

“Reliable partner for large‑scale production.”

David Kim, VP of Manufacturing, GenericMed Corp.

“Our 12‑month contract for 15 tonnes per year has been flawless. No batch failures, on‑time deliveries, and a 27% cost reduction versus our previous supplier.”

About the Author

Author Avatar

Dr. Alan Cheng, Ph.D.

Senior Regulatory & Quality Director at Global Technology Co., Ltd, with 15 years of experience in API development, GMP compliance, and international trade. Former senior analyst at FDA’s Office of Pharmaceutical Quality, author of 30+ peer‑reviewed papers on alpha‑glucosidase inhibitors, and regular speaker at CPhI & DIA conferences.

Contact: service@huanqiukeji9.com | Tel: +86 199 4383 0844

Global Technology Co., Ltd | No. 14, 863 Park, Zhongyuan District, Zhengzhou City, Henan Province, China

Tel: +86 199 4383 0844 | Email: service@huanqiukeji9.com

All information is provided in good faith. Prices, availability, and specifications are subject to change without notice. Please refer to our Contact Page for the latest details and privacy policy.

If you are interested in our products, you can choose to leave your information here, and we will be in touch with you shortly.